Information Library
Results for: Our Expertise - Late Phase
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Understanding the Complexity of HTA Networks
Presentation — November 27, 2011
As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service. -
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
Quintiles Names New Global Head of Clinical & Data Operations
Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.
-
Methods Matter
White Paper — July 18, 2011
As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs. -
A Focus on CNS
Brochure — July 1, 2011
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. -
PharmAsia News Article Reprint
Media Coverage — March 1, 2010
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.
Page 1 of 1 (6 results)
